121 related articles for article (PubMed ID: 6199100)
1. Combined modality therapy in Stage III and Stage IIIE diffuse large cell lymphomas.
Velasquez W; Fuller LM; Oh KK; Hagemeister FB; Sullivan JA; Manning JT; Shullenberger CC
Cancer; 1984 Apr; 53(7):1478-83. PubMed ID: 6199100
[TBL] [Abstract][Full Text] [Related]
2. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Velasquez WS; McLaughlin P; Fuller LM; Allen PK; Tucker SL; Swan F; Rodriguez MA; Hagemeister FB; Cabanillas FF
Cancer; 1994 May; 73(9):2408-16. PubMed ID: 7513251
[TBL] [Abstract][Full Text] [Related]
3. Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma.
Jagannath S; Velasquez WS; Tucker SL; Fuller LM; McLaughlin PW; Manning JT; North LB; Cabanillas FC
J Clin Oncol; 1986 Jun; 4(6):859-65. PubMed ID: 2423653
[TBL] [Abstract][Full Text] [Related]
4. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G
J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089
[TBL] [Abstract][Full Text] [Related]
5. Thyroid lymphomas stages IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment.
Vigliotti A; Kong JS; Fuller LM; Velasquez WS
Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1807-12. PubMed ID: 2428787
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy.
Jones SE; Miller TP; Connors JM
J Clin Oncol; 1989 Sep; 7(9):1186-91. PubMed ID: 2671279
[TBL] [Abstract][Full Text] [Related]
7. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
[TBL] [Abstract][Full Text] [Related]
8. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
[TBL] [Abstract][Full Text] [Related]
9. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
10. A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphoma.
Lee R; Cabanillas F; Bodey GP; Freireich EJ
J Clin Oncol; 1986 Oct; 4(10):1455-61. PubMed ID: 2428947
[TBL] [Abstract][Full Text] [Related]
11. Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).
Bernstein JI; Coleman CN; Strickler JG; Dorfman RF; Rosenberg SA
J Clin Oncol; 1986 Jun; 4(6):847-58. PubMed ID: 3711961
[TBL] [Abstract][Full Text] [Related]
12. Primary mediastinal large B-cell lymphoma: the need for prospective controlled clinical trials.
Bieri S; Roggero E; Zucca E; Bertoni F; Pianca S; Sanna P; Pedrinis E; Bernier J; Cavalli F
Leuk Lymphoma; 1999 Nov; 35(5-6):537-44. PubMed ID: 10609791
[TBL] [Abstract][Full Text] [Related]
13. Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.
McLaughlin P; Fuller L; Redman J; Hagemeister F; Durr E; Allen P; Holmes L; Velasquez W; Swan F; Cabanillas F
Ann Oncol; 1991 Feb; 2 Suppl 2():137-40. PubMed ID: 1710918
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
15. Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregionale per lo Studio dei Linfomi e Leucenie (GIMURELL) study.
Cabras MG; Mamusa AM; Vitolo U; Freilone R R; Dessalvi P; Orsucci L; Tonso A; Levis A; Liberati M; Lay G; Angelucci E
Leuk Lymphoma; 2009 Sep; 50(9):1475-81. PubMed ID: 19579074
[TBL] [Abstract][Full Text] [Related]
16. A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.
Todd M; Cadman E; Spiro P; Bertino J; Farber L; Waldron J; Fischer D
J Clin Oncol; 1984 Sep; 2(9):986-93. PubMed ID: 6206207
[TBL] [Abstract][Full Text] [Related]
17. Gastric lymphomas: chemotherapy as a primary treatment.
Solidoro A; Payet C; Sanchez-Lihon J; Montalbetti JA
Semin Surg Oncol; 1990; 6(4):218-25. PubMed ID: 1697094
[TBL] [Abstract][Full Text] [Related]
18. Non-Hodgkin's lymphomas in Turkey: eighteen years' experience at the Hacettepe University.
Barista I; Tekuzman G; Firat D; Baltali E; Kansu E; Kars A; Ozisik Y; Ruacan S; Uzunalimoğlu B; Karaağaoğlu E
Jpn J Cancer Res; 1994 Dec; 85(12):1200-7. PubMed ID: 7531679
[TBL] [Abstract][Full Text] [Related]
19. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
20. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
Gordon LI; Andersen J; Colgan J; Glick J; Resnick GD; O'Connell M; Cassileth PA
Cancer; 1995 Feb; 75(3):865-73. PubMed ID: 7530168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]